MBIO
Price
$1.24
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
5.21M
PTHS
Price
$16.18
Change
-$0.32 (-1.94%)
Updated
Jul 3 closing price
Capitalization
N/A
61 days until earnings call
Interact to see
Advertisement

MBIO vs PTHS

Header iconMBIO vs PTHS Comparison
Open Charts MBIO vs PTHSBanner chart's image
Mustang Bio
Price$1.24
Change-$0.00 (-0.00%)
Volume$72.91K
Capitalization5.21M
Pelthos Therapeutics
Price$16.18
Change-$0.32 (-1.94%)
Volume$13.51K
CapitalizationN/A
MBIO vs PTHS Comparison Chart in %
Loading...
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBIO vs. PTHS commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBIO is a Hold and PTHS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (MBIO: $1.19 vs. PTHS: $16.18)
Brand notoriety: MBIO and PTHS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBIO: 78% vs. PTHS: 12%
Market capitalization -- MBIO: $5.21M vs. PTHS: $0
MBIO [@Biotechnology] is valued at $5.21M. PTHS’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBIO’s FA Score shows that 0 FA rating(s) are green whilePTHS’s FA Score has 0 green FA rating(s).

  • MBIO’s FA Score: 0 green, 5 red.
  • PTHS’s FA Score: 0 green, 5 red.
According to our system of comparison, both MBIO and PTHS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBIO’s TA Score shows that 3 TA indicator(s) are bullish while PTHS’s TA Score has 5 bullish TA indicator(s).

  • MBIO’s TA Score: 3 bullish, 6 bearish.
  • PTHS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PTHS is a better buy in the short-term than MBIO.

Price Growth

MBIO (@Biotechnology) experienced а +15.53% price change this week, while PTHS (@Biotechnology) price change was +1283.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MBIO is expected to report earnings on May 14, 2025.

PTHS is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS YTD gains are higher at: 2424.961 vs. MBIO (-86.554).
MBIOPTHSMBIO / PTHS
Capitalization5.21MN/A-
EBITDA-10.6MN/A-
Gain YTD-86.5542424.961-4%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash14.2MN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
MBIO: Fundamental Ratings
MBIO
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MBIOPTHS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY625.344.89
+0.79%
SPDR® S&P 500® ETF
BTC.X109647.980000788.656250
+0.72%
Bitcoin cryptocurrency
AAPL213.551.11
+0.52%
Apple
TSLA315.35-0.30
-0.10%
Tesla
GME23.59-0.36
-1.50%
GameStop Corp

MBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBIO has been closely correlated with SLRX. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MBIO jumps, then SLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBIO
1D Price
Change %
MBIO100%
-4.03%
SLRX - MBIO
71%
Closely correlated
-1.17%
MDGL - MBIO
50%
Loosely correlated
-0.43%
ORMP - MBIO
44%
Loosely correlated
+0.93%
AXON - MBIO
40%
Loosely correlated
+2.70%
SCNI - MBIO
38%
Loosely correlated
-2.95%
More

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been closely correlated with SONN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTHS jumps, then SONN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-1.91%
SONN - PTHS
70%
Closely correlated
-5.54%
LIXT - PTHS
34%
Loosely correlated
+40.10%
MBIO - PTHS
29%
Poorly correlated
-4.03%
ELEV - PTHS
28%
Poorly correlated
+2.46%
CYBN - PTHS
27%
Poorly correlated
+7.59%
More